This Article Full Text Full Text (PDF) All Versions of this Article: 35/10/2326    most recent 01.STR.0000141937.80760.10v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aiyagari, V. Articles by Diringer, M. N. Search for Related Content PubMed PubMed Citation Articles by Aiyagari, V. Articles by Diringer, M. N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stroke Related Collections Thrombolysis Cerebrovascular disease/stroke Acute Cerebral Infarction

(Stroke. 2004;35:2326.)
© 2004 American Heart Association, Inc.

Original Contributions

Hourly Blood Pressure Monitoring After Intravenous Tissue Plasminogen Activator for Ischemic Stroke

Does Everyone Need It?

From the Department of Neurology (V.A., A.R.Z., M.N.D.), Washington University School of Medicine, St. Louis, Mo; and the National Institute of Mental Health and Neurological Sciences (A.G.), Bangalore, India.

Correspondence to Dr Venkatesh Aiyagari, Department of Neurology, Washington University School of Medicine, Campus Box 8111, 660 S. Euclid Avenue, St. Louis, MO 63110. E-mail aiyagariv{at}neuro.wustl.edu

Background and Purpose— Blood pressure (BP) control is considered essential in patients treated with tissue plasminogen activator (tPA) for ischemic stroke, and it is recommended that BP be monitored every 15 minutes to 1 hour for 24 hours in these patients. We postulated that patients whose BP is not initially elevated are unlikely to have elevated BP later and, therefore, may not need prolonged BP monitoring.

Methods— We performed a retrospective chart review of patients treated with intravenous tPA for ischemic stroke over a 3-year period. Patients with incomplete records were excluded.

Results— Seventy-nine patients (35 male, age 68.8±14.3 years) were studied. Before tPA treatment, 16 patients (20%) had hypertension (systolic BP 185 or diastolic BP 110 mm Hg). All 16 patients had subsequent hypertension over the next 24 hours. Of the remaining 63, 27 patients (43%) had hypertension (systolic BP 180 or diastolic BP 105 mm Hg) within the first 6 hours. An additional 4 had minor transient systolic elevations (182 mm Hg) after 6 hours that normalized without treatment. Neurological worsening, seen in 13 patients (17%), was not associated with the presence of hypertension (initial or subsequent).

Conclusions— In patients receiving tPA for stroke, absence of hypertension at presentation does not preclude subsequent increase in blood pressure. However, if blood pressure is not elevated during the first 6 hours, subsequent hypertension over the next 18 hours is unlikely. This study is small and retrospective, and needs to be repeated in a larger prospective cohort. However, our results provide preliminary evidence to suggest that where resources are scarce, these patients may be discharged from the intensive care unit earlier than the recommended 24 hours, provided that they are not at high risk for neurological deterioration.

Key Words: blood pressure • stroke • stroke units • tissue plasminogen activator

This article has been cited by other articles:

				A. I. Qureshi Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management Circulation, July 8, 2008; 118(2): 176 - 187. [Full Text] [PDF]